Babcock & Wilcox shares surge 10.03% after hours on $40M contract, $80M carbon capture project, and Siemens partnership.
ByAinvest
Tuesday, Feb 3, 2026 6:47 pm ET1min read
BW--
Babcock & Wilcox Enterprises surged 10.03% in after-hours trading following a series of strategic and financial developments. The stock hit a 52-week high of $10.98, reflecting a 684.89% annual gain, driven by a $40 million contract for wet gas scrubbing technology in Canada, an $80 million carbon capture project in the U.S., and a partnership with Siemens Energy for a one-gigawatt power project. The company also redeemed $26 million in senior notes, reducing debt, and expanded its board with Dr. Homaira Akbari. These milestones underscore investor confidence in Babcock & Wilcox’s market positioning, technological innovation, and operational execution, aligning with the sharp post-market rally.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet